Neutral impactResults

Medicamen Biotech Limited — Outcome of Board Meeting

NSE 17 min ago·13 Nov 2026, 10:43 am
Medicamen Biotech

Medicamen Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Affected stocks

Neutral1 stock

Medicamen Biotech

MEDICAMEQ Neutral

₹271.80

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Medicamen Biotech (MEDICAMEQ).
  • Category: Results.

Why it matters

A routine update for Medicamen Biotech. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news
Creative Eye

Creative Eye Limited — Outcome of Board Meeting

Creative Eye₹6.20▲ 0.00%

NSE · 1 min ago

Creative Eye

Creative Eye Limited — Integrated Filing- Financial

Creative Eye₹6.20▲ 0.00%

NSE · 1 min ago

Electrosteel Castings

Electrosteel Castings Limited — Change in Directors/KMP/SMP/Auditor/RTA

Electrosteel Castings₹70.96▲ 0.00%

NSE · 2 min ago

Solarworld Energy Solutions

Solarworld Energy Solutions Limited — Press Release

Solarworld Energy Solutions₹117.12▲ 0.00%

NSE · 2 min ago

Company NSE

Radhakrishna Securitisation Trust — Others

NSE · 2 min ago

Company NSE

Kotak Securities Limited — Confirmation of Redemption/Payment of Interest and Principal

NSE · 3 min ago

Tata Sons rejects Noel’s request for audio-video recording of Sept 17 board-meet

BusinessLine · 3 min ago

Shriram Properties

Shriram Properties Limited — Investor Presentation

Shriram Properties₹73.08▲ 0.00%

NSE · 3 min ago

M K Proteins

M K Proteins Limited — Outcome of Board Meeting

M K Proteins₹3.98▲ 0.00%

NSE · 5 min ago

Latest headlines

More news
Stocks BW Businessworld

Sensex, Nifty Fall As Crude Oil And Inflation Pressures Weigh On Markets

BW Businessworld · 2 min ago

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.